Cargando…
SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers
OBJECTIVE: To characterize the SARS-CoV-2 testing cascade and associated barriers in three US states. METHODS: We recruited participants from Florida, Illinois, and Maryland (~1000/state) for an online survey September 16 – October 15, 2020. The survey covered demographics, COVID-19 symptoms, and ex...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781341/ https://www.ncbi.nlm.nih.gov/pubmed/33398298 http://dx.doi.org/10.1101/2020.12.23.20248789 |
_version_ | 1783631657624928256 |
---|---|
author | Clipman, Steven J. Wesolowski, Amy Mehta, Shruti H. Agarwal, Smisha Cobey, Sarah E. Cummings, Derek A.T. Gibson, Dustin G. Labrique, Alain B. Kirk, Gregory D. Solomon, Sunil S. |
author_facet | Clipman, Steven J. Wesolowski, Amy Mehta, Shruti H. Agarwal, Smisha Cobey, Sarah E. Cummings, Derek A.T. Gibson, Dustin G. Labrique, Alain B. Kirk, Gregory D. Solomon, Sunil S. |
author_sort | Clipman, Steven J. |
collection | PubMed |
description | OBJECTIVE: To characterize the SARS-CoV-2 testing cascade and associated barriers in three US states. METHODS: We recruited participants from Florida, Illinois, and Maryland (~1000/state) for an online survey September 16 – October 15, 2020. The survey covered demographics, COVID-19 symptoms, and experiences around SARS-CoV-2 PCR testing in the prior 2 weeks. Logistic regression was used to analyze associations with outcomes of interest. RESULTS: Overall, 316 (10%) of 3,058 respondents wanted/needed a test in the two weeks prior to the survey. Of these, 166 (53%) were able to get tested and 156 (94%) received results; 53% waited ≥ 8 days to get results from when they wanted/needed a test. There were no significant differences by state. Among those wanting/needing a test, getting tested was significantly less common among men (aOR: 0.46) and those reporting black race (aOR: 0.53) and more common in those reporting recent travel (aOR: 3.35). CONCLUSIONS: There is an urgent need for a national communication strategy on who should get tested and where one can get tested. Additionally, measures need to be taken to improve access and reduce turn-around-time. |
format | Online Article Text |
id | pubmed-7781341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-77813412021-01-05 SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers Clipman, Steven J. Wesolowski, Amy Mehta, Shruti H. Agarwal, Smisha Cobey, Sarah E. Cummings, Derek A.T. Gibson, Dustin G. Labrique, Alain B. Kirk, Gregory D. Solomon, Sunil S. medRxiv Article OBJECTIVE: To characterize the SARS-CoV-2 testing cascade and associated barriers in three US states. METHODS: We recruited participants from Florida, Illinois, and Maryland (~1000/state) for an online survey September 16 – October 15, 2020. The survey covered demographics, COVID-19 symptoms, and experiences around SARS-CoV-2 PCR testing in the prior 2 weeks. Logistic regression was used to analyze associations with outcomes of interest. RESULTS: Overall, 316 (10%) of 3,058 respondents wanted/needed a test in the two weeks prior to the survey. Of these, 166 (53%) were able to get tested and 156 (94%) received results; 53% waited ≥ 8 days to get results from when they wanted/needed a test. There were no significant differences by state. Among those wanting/needing a test, getting tested was significantly less common among men (aOR: 0.46) and those reporting black race (aOR: 0.53) and more common in those reporting recent travel (aOR: 3.35). CONCLUSIONS: There is an urgent need for a national communication strategy on who should get tested and where one can get tested. Additionally, measures need to be taken to improve access and reduce turn-around-time. Cold Spring Harbor Laboratory 2020-12-24 /pmc/articles/PMC7781341/ /pubmed/33398298 http://dx.doi.org/10.1101/2020.12.23.20248789 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Article Clipman, Steven J. Wesolowski, Amy Mehta, Shruti H. Agarwal, Smisha Cobey, Sarah E. Cummings, Derek A.T. Gibson, Dustin G. Labrique, Alain B. Kirk, Gregory D. Solomon, Sunil S. SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers |
title | SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers |
title_full | SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers |
title_fullStr | SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers |
title_full_unstemmed | SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers |
title_short | SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers |
title_sort | sars-cov-2 testing in florida, illinois, and maryland: access and barriers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781341/ https://www.ncbi.nlm.nih.gov/pubmed/33398298 http://dx.doi.org/10.1101/2020.12.23.20248789 |
work_keys_str_mv | AT clipmanstevenj sarscov2testinginfloridaillinoisandmarylandaccessandbarriers AT wesolowskiamy sarscov2testinginfloridaillinoisandmarylandaccessandbarriers AT mehtashrutih sarscov2testinginfloridaillinoisandmarylandaccessandbarriers AT agarwalsmisha sarscov2testinginfloridaillinoisandmarylandaccessandbarriers AT cobeysarahe sarscov2testinginfloridaillinoisandmarylandaccessandbarriers AT cummingsderekat sarscov2testinginfloridaillinoisandmarylandaccessandbarriers AT gibsondusting sarscov2testinginfloridaillinoisandmarylandaccessandbarriers AT labriquealainb sarscov2testinginfloridaillinoisandmarylandaccessandbarriers AT kirkgregoryd sarscov2testinginfloridaillinoisandmarylandaccessandbarriers AT solomonsunils sarscov2testinginfloridaillinoisandmarylandaccessandbarriers |